• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Latest News

The Weekly Roundup: June 2-6
The Weekly Roundup: June 2-6

June 9th 2025

In case you missed it, this week we had news about denifanstat's promising phase 3 results for acne, emerging therapies in lichen planus, initial insights from RAD 2025, and more.

The Rx Recap: June 1-7
The Rx Recap: June 1-7

June 9th 2025

Q&A: Dosing Flexibility Strategies for Oral and Biologic Therapeutics in AD With Raj Chovatiya, MD, PhD, MSCI
Q&A: Dosing Flexibility Strategies for Oral and Biologic Therapeutics in AD With Raj Chovatiya, MD, PhD, MSCI

June 8th 2025

Recognizing Topical Steroid Withdrawal and Advancing Therapeutic Precision
Recognizing Topical Steroid Withdrawal and Advancing Therapeutic Precision

June 8th 2025

Late-Breaking Data: Real-World Data from Canada Shows Upadacitinib is Effective in Patients With Moderate to Severe AD With Inadequate Response to Dupilumab
Late-Breaking Data: Real-World Data from Canada Shows Upadacitinib is Effective in Patients With Moderate to Severe AD With Inadequate Response to Dupilumab

June 8th 2025

Register Now for Revolutionizing Atopic Dermatitis
Introducing Dermatology Times' 2025 Editor in Chief
Explore Emerging Treatments and Clinical Tools for CHE
Subscribe Now for Free - eNL
Explore Our Conference Coverage
Subscribe for Free - Print
Advancing AD Treatment: Expert-Led Case Discussions
Breaking Down New Treatment Options in Pediatric Atopic Dermatitis
Stay Informed!
Don't miss the latest in dermatology news
Managing Prurigo Nodularis

Conference Coverage

View All
Q&A: Dosing Flexibility Strategies for Oral and Biologic Therapeutics in AD With Raj Chovatiya, MD, PhD, MSCI
Q&A: Dosing Flexibility Strategies for Oral and Biologic Therapeutics in AD With Raj Chovatiya, MD, PhD, MSCI

June 8th 2025

Recognizing Topical Steroid Withdrawal and Advancing Therapeutic Precision
Recognizing Topical Steroid Withdrawal and Advancing Therapeutic Precision

June 8th 2025

Late-Breaking Data: Real-World Data from Canada Shows Upadacitinib is Effective in Patients With Moderate to Severe AD With Inadequate Response to Dupilumab
Late-Breaking Data: Real-World Data from Canada Shows Upadacitinib is Effective in Patients With Moderate to Severe AD With Inadequate Response to Dupilumab

June 8th 2025

Reviewing the Multifactorial Nature of Chronic Hand Eczema and Upcoming Delgocitinib
Reviewing the Multifactorial Nature of Chronic Hand Eczema and Upcoming Delgocitinib

June 8th 2025

Latest Videos

All News

© 2025 MJH Life Sciences

All rights reserved.